1.Regularity of drugs compatibility of anti-hepatoma traditional Chinese medicine ancient prescriptions and risk evaluation of anti-hepatoma new drug research and development.
Jing ZHANG ; Hong-Fa LI ; Wei FAN ; Zhen LIU ; Shu-Li MAN ; Shu-Yong SI ; Wen-Yuan GAO
China Journal of Chinese Materia Medica 2014;39(19):3870-3875
Traditional Chinese ancient prescriptions have been used for treatment of liver cancer for a long history and the scientific and rational compatibility is a great wealth for modern research and development (R&D) of new drugs. The research and development of new drugs are often accompanied with a large investment, a long cycle and a high risk, especially for the anti-tumor drugs R&D which are facing more risks and lower successful rate. In this research, the regularity of compatibility of drugs was analyzed from 124 anti-hepatoma ancient prescriptions by computer program. The results can offer help to the R&D of anti-hepatoma new drugs and reduce the risk of drug screening. In addition, we surveyed 22 companies in this field from six provinces such as Beijing, Shanghai, Tianjin and so on and obtained 240 risk assessment questionaires. Then we used qualitative analysis method to interpret the greatest impacts for the risks in the process of R&D, production and sales of anti-hepatoma new drugs. The study provides a basis for anti-liver cancer drugs R&D researchers, who can take effective measures to reduce the R&D risks and improve successful rate.
Carcinoma, Hepatocellular
;
drug therapy
;
history
;
China
;
Drug Discovery
;
history
;
Drug Incompatibility
;
Drug Prescriptions
;
history
;
Drugs, Chinese Herbal
;
history
;
therapeutic use
;
History, Ancient
;
Humans
;
Liver Neoplasms
;
drug therapy
;
history
;
Research
;
history
2.Coexistence of Amyotrophic Lateral Sclerosis in the Proband of an X-Linked Charcot-Marie-Tooth Disease Type 1 Pedigree in China.
Shu Yan FENG ; Shu Man FENG ; Liu Yi LI ; Zhang Yu ZOU
Journal of Clinical Neurology 2018;14(2):261-263
No abstract available.
Amyotrophic Lateral Sclerosis*
;
Charcot-Marie-Tooth Disease*
;
China*
;
Pedigree*
3.Dynamic monitoring risk of anti-hepatoma new drug development.
Jing ZHANG ; Wei FAN ; Hong-Fa LI ; Shu-Li MAN ; Zhen LIU ; Wen-Yuan GAO
China Journal of Chinese Materia Medica 2014;39(20):4050-4053
Risk monitoring of new Chinese patent anti-hepatoma drugs is tracking recognized risks and residual risks, identifying emerging risk and ensure the implementation of the plan, estimating the process of reducing effectiveness. The paper is mainly through understanding the status of Chinese patent anti-hepatoma drugs, the content, characteristic and analysis method of dynamic risk monitoring, and then select the risk control indicators, collect risk information. Finally, puts forward the thought of anti-hepatoma drugs listed evaluation in our country, and try to establish the model of dynamic risk management of anti-hepatoma drugs.
Antineoplastic Agents, Phytogenic
;
adverse effects
;
economics
;
therapeutic use
;
Carcinoma, Hepatocellular
;
drug therapy
;
Drug Discovery
;
economics
;
legislation & jurisprudence
;
organization & administration
;
Drug and Narcotic Control
;
economics
;
legislation & jurisprudence
;
organization & administration
;
Drugs, Chinese Herbal
;
adverse effects
;
economics
;
therapeutic use
;
Humans
;
Liver Neoplasms
;
drug therapy
;
Product Surveillance, Postmarketing
4.The effect of chlamydiaphage phiCPG1 capsid protein Vp1 on the Chlamydia trachomatis
Yuanjun LIU ; Shu-ping HOU ; Jiu-rong WEI ; Yan LI ; Man-li QI ; Hui-ping WANG ; Quan-zhong LIU
Chinese Journal of Microbiology and Immunology 2012;32(5):403-407
Objective To investigate the effect of recombinant chlamydiaphage phiCPG1 capsid protein Vp1 on Chlamydia trachomatis(Ct) after Vp1 was co-cultured with Ct (reference strains and clinical strains).Methods The recombinant chlamydiaphage phiCPG1 capsid protein Vp1 was expressed and purified.Equal amount of Ct standard strains (E/UW-5/Cx and D/UW-3/Cx) or clinical strains,which had been incubated with Vp1 protein at the concentration of 53 μg/ml for 3 h at room temperature,were inoculated into McCoy.After cell culture,idione stain and transmission electron microscope were used to observe the effect of Vp1 on the Ct.The effect of Vp1 protein on the cell line McCoy was determined by MTT assay,the responses of Escherichia coli BL21 and DH5α toward Vp1 protein were determined using broth microdilution assays.Results Vp1 had obviously inhibitive effect on Ct,the inhibition ratios were about 40%-70%in clinical strains,72% in reference strain D and 78% in E,respectively.Abnormally enlarged RBs were observed after Vp1-treatment and Vp1 could arrest chlamydial developmental cycle using electron microscope.There was no effect of Vp1 on McCoy cells or bacteria BL21 or DH5α.Conclusion The recombinant Vp1 from phiCPG1 has obviously inhibitive effect on the growth of Ct,it will be helpful for the treatment of Ct infection in clinic.
5.Progress of mesoporous silica nanoparticles in targeting drug delivery system of antitumor drug.
Hong-min ZHANG ; Shu MO ; Xiao-qian LIU ; Fu-man HAN ; Jin-yu WANG ; Zhi-min WANG
China Journal of Chinese Materia Medica 2015;40(17):3450-3455
Currently, chemotherapy is one of the main therapy for cancer. But the traditional antitumor drugs are systemic distribution in vivo, they are difficult to achieve an effective drug concentration in the tumor tissue and don't have the ability to distinguish normal cells and tumor cells by themselves, that cause systemic toxicity easily and can not meet the clinical needs. With the research on mesoporous silica nanoparticles (MSNs) deepening, more and more attention in the drug delivery system have been payed to in recent years, because of its unique physicochemical structure characteristics, it has the effect on specific targets, directly inhibits the tumor cell growth, reduces the side effects to normal cells, tissues and organs and can be long-term medication, etc. It is expected to be excellent carriers of antitumor drugs. MSNs application in the field of cancer treatment has now become a hot research field of medicine. In this paper, the latest research about MSNs in antitumor drugs targeting delivery system from 2008 to 2015 is summarized, including the application of MSNs separately in antitumor drug targeting, passive targeting, active targeting, physical or chemical conditions response targeting and other compound targeting drug delivery system. We expect it to provide a reference to the toxicity reducing and efficacy enhancing and further development of chemical medicine, natural medicine and monomeric compound of chinese herbal medicine.
Animals
;
Antineoplastic Agents
;
chemistry
;
pharmacology
;
Drug Delivery Systems
;
methods
;
trends
;
Humans
;
Nanoparticles
;
chemistry
;
Neoplasms
;
drug therapy
;
Silicon Dioxide
;
chemistry
6.Studies on hyaluronic acid as dendifier in Shuanghuanglian eye-drops.
Man-ling MA ; Lu LIU ; Shu-ying SUN
China Journal of Chinese Materia Medica 2005;30(16):1246-1248
OBJECTIVETo study the possibility of hyaluronic acid as densifier of Shuanguangliao eye-drops.
METHODThe factors related with hyaluronic acid s viscosity, such as pH-value and storing temperature, are tested in this experiment. At the same time, we checked the stimulation, stability of the densifier.
RESULTThere was not effect on viscosity of pH-value and storing temperature. No stimulation on the eye was found after densified with hyaluronic acid. The viscosity properties of hyaluronic acid are stablile.
CONCLUSIONThe hyaliuronic acid added to Shuanghuanglian eye-drops are stabiliable and it can be applied in eye-drops. The increased viscosity is benefit to extend the residence time of drug in eye.
Animals ; Anti-Bacterial Agents ; administration & dosage ; isolation & purification ; Drug Carriers ; Drug Combinations ; Drugs, Chinese Herbal ; administration & dosage ; isolation & purification ; Eye ; drug effects ; Female ; Hyaluronic Acid ; pharmacology ; toxicity ; Hydrogen-Ion Concentration ; Male ; Ophthalmic Solutions ; administration & dosage ; isolation & purification ; Plants, Medicinal ; chemistry ; Rabbits ; Temperature ; Viscosity ; drug effects
7.Expression and significance of B7-H1 and its receptor PD-1 in human gastric carcinoma.
Shu-Man LIU ; Qing MENG ; Qin-Xian ZHANG ; Sheng-Dian WANG ; Zhan-Ju LIU ; Xie-Fu ZHANG
Chinese Journal of Oncology 2008;30(3):192-195
OBJECTIVEThe B7-H1/PD-1 co-signaling pathway has recently been found to play a pivotal role in the immune evasion of tumor cells from host immune system. The aim of this study was to examine the B7-H1 and PD-1 expression and TILs status in gastric cancer and to elucidate the clinical relevance of B7-H1 and PD-1 to the pathogenesis of gastric carcinoma.
METHODSImmunohistochemistry and ANAE histochemical staining were used to investigate the in situ expression of B7-H1 and PD-1 and TILs status in the gastric tissues. RT-PCR was used to explore B7-H1 and PD-1 expression at the transcriptional level. The B7-H1 expression at protein level was detected by Western blot.
RESULTSExpression of B7-H1 and PD-1 was found to be increased in gastric carcinoma, but absent in normal gastric tissue. B7-H1 expression in gastric carcinoma was inversely correlated with TILs infiltration. B7-H1 but not PD-1 expression in tumor tissue was significantly correlated with some clinicopathhological variables including depth of invasion, lymph node metastasis and distant metastasis.
CONCLUSIONB7-H1 and PD-1 expressions are increased in gastric carcinoma. This signaling pathway may inhibit antitumor immune responses in gastric carcinoma. B7-H1 expression plays a critical role in the pathogenesis of human gastric carcinoma,and might be a promising prognostic marker and therapeutic target in the treatment of this disease.
Adult ; Aged ; Antigens, CD ; genetics ; metabolism ; Apoptosis Regulatory Proteins ; genetics ; metabolism ; B7-H1 Antigen ; CD4-Positive T-Lymphocytes ; immunology ; Female ; Humans ; Lymphatic Metastasis ; Lymphocyte Subsets ; immunology ; Lymphocytes, Tumor-Infiltrating ; immunology ; Male ; Middle Aged ; Neoplasm Invasiveness ; Neoplasm Metastasis ; Neoplasm Staging ; Programmed Cell Death 1 Receptor ; RNA, Messenger ; metabolism ; Stomach Neoplasms ; genetics ; immunology ; pathology
8.Associations of SUMO4 polymorphisms with tacrolimus concentrations in Chinese renal transplant recipients.
Xiao-Man LIU ; Jia-Li LI ; Hong-Yang WANG ; Qian FU ; Jun LI ; Liu SHU ; Ping-Ping SUN ; Chang-Xi WANG ; Min HUANG
Acta Pharmaceutica Sinica 2015;50(2):180-184
The study aims to investigate the associations of SUMO4 polymorphisms with tacrolimus concentrations in Chinese renal transplant recipients. Blood samples and clinical data were collected from 132 renal transplant recipients with tacrolimus treatment. CYP3A5*3 genotypes were detected by PCR-RFLP, and SUMO4 (rs237024, rs237025) genotypes were detected by Sequenom® MassARRAY system. SUMO4 rs237024 and rs237025 genotypes were in complete linkage disequilibrium (D' = 1). The dose-adjusted concentration of tacrolimus in SUMO4 rs237024A-rs237025A (GA-GA +AA-AA) carriers was considerably higher than that in GG-GG carriers (P < 0.05). After stratification by CYP3A5*3 genotypes, SUMO4 rs237024A-rs237025A carriers (GA-GA+AA-AA) had a higher dose-adjusted tacrolimus concentration than that in GG carriers in CYP3A5 expresser (P < 0.05). The results illustrated that SUMO4 rs237024 and rs237025 polymorphisms were associated with tacrolimus concentrations, and the test of these genotypes may be useful for individualized medicine of tacrolimus.
Asian Continental Ancestry Group
;
genetics
;
Cytochrome P-450 CYP3A
;
genetics
;
Genotype
;
Humans
;
Immunosuppressive Agents
;
blood
;
therapeutic use
;
Kidney
;
Kidney Transplantation
;
Linkage Disequilibrium
;
Polymorphism, Single Nucleotide
;
Small Ubiquitin-Related Modifier Proteins
;
genetics
;
Tacrolimus
;
blood
;
therapeutic use
9.Vitamin E inhibits homocysteine-mediated smooth muscle cell proliferation.
Tong ZOU ; Nan LIU ; Shu-de LI ; Yong-chun SU ; Yong MAN ; Di LU
Journal of Southern Medical University 2007;27(6):783-786
OBJECTIVETo investigate the role of reactive oxygen species (ROS) and the effect of vitamin E on proliferation of vascular smooth muscle cells (VSMCs) induced by homocysteine.
METHODSDNA synthesis in the VSMCs cells was measured using [3H]-thymidine incorporation assay, and the cell number determined by trypan blue method. The level of ROS in the cells was determined using DCF-DA as the fluorescence probe.
RESULTSHomocysteine promoted VSMC DNA synthesis, proliferation, and ROS production. Cysteine resulted in increased ROS production in VSMCs, but had no significant effect on DNA synthesis and cell proliferation. Catalase significantly inhibited ROS production induced by homocysteine, but did not significantly inhibited homocysteine-mediated proliferation of VSMCs. While alpha-tocopherol and beta-tocopherol both suppressed increased ROS production induced by homocysteine in VSMCs, only alpha-tocopherol significantly inhibited homocysteine-mediated VSMC proliferation.
CONCLUSIONROS is not associated with VSMC proliferation, and vitamin E-induced suppression of VSMC proliferation is probably related to protein kinase C inhibition.
Animals ; Antioxidants ; pharmacology ; Cell Proliferation ; drug effects ; Cells, Cultured ; Homocysteine ; pharmacology ; Muscle, Smooth ; cytology ; drug effects ; metabolism ; Muscle, Smooth, Vascular ; cytology ; drug effects ; metabolism ; Rats ; Reactive Oxygen Species ; metabolism ; Vitamin E ; pharmacology ; alpha-Tocopherol ; pharmacology ; beta-Tocopherol ; pharmacology
10.Semen-derived enhancer of viral infection--a key factor in sexual transmission of HIV.
Jiang-Man DUAN ; Jia-Yin QIU ; Sui-Yi TAN ; Shu-Wen LIU ; Lin LI
Chinese Journal of Virology 2012;28(1):84-88
Semen-derived enhancer of viral infection(SEVI) is a peptide fragment (PAP248-286) from prostatic acid phosphatase(PAP), which can enhance human immunodeficiency virus infection. The mechanisms of SEVI include: (1) SEVI with several cationic amino acid residues reduced electrostatic repulsion between HIV virus and the target cells; (2) The disorder state of SEVI in the human body fluids was helpful to the interaction between virus and the target cell membranes; (3) SEVI could capture HIV particles directly and speed the velocity of virus on the surface of the target cells and improve adsorption and fusion. Currently, the substances of inhibiting SEVI activity include: EGCG from green tea, small molecule compound of aminoquinoline Surfen, ThT analogs BTA-EG6. Those compounds might block the combination of HIV and SEVI or prevent the formation of amyloid fibers, and then reduce the enhancement of SEVI. The studies on the biological characteristics and mechanisms of SEVI have a big benefit for the prevention and treatment of HIV infection.
HIV Infections
;
etiology
;
transmission
;
Humans
;
Male
;
Semen
;
physiology
;
Sexually Transmitted Diseases, Viral
;
etiology
;
Static Electricity